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Exposure of isolated hepatocytes to extracellular ATP, cystamine orionophore A23187 was associated with 
an increase in cytosolic Ca2+ concentration, a stimulation of intracellular proteolysis, and the appearance 
of plasma membrane blebs which preceded the loss of cell viability. Both bleb formation and cell killing 
were prevented when inhibitors of Ca 2+-activated neutral proteases, such as antipain or leupeptin, were in- 
cluded in the incubation medium, whereas inhibitors of lysosomal proteases had no effect. Thus, the activa- 
tion of a Caz+-dependent, non-lysosomal proteolytic system appears to be responsible for the plasma mem- 
brane blebbing and, ultimately, the cytotoxicity associated with treatment of hepatocytes with agents that 
disrupt intracellular Caz+ homeostasis. 
Cytosolic Ca2+ Blebbing 
1. INTRODUCTION 
Previous studies in our and other laboratories 
have shown that formation of plasma membrane 
blebs is an early morphological sign of chemical 
and ischemic injury to isolated, intact cells [1,2]. 
The occurrence of plasma membrane blebbing has 
been described not only in isolated cell systems but 
also in cells in culture [3] and in tissue sections [4], 
indicating that this phenomenon is not limited to 
one experimental model. The formation of plasma 
membrane blebs has been related to modification 
of the cytoskeleton, inasmuch as substances like 
cytochalasin B or D and phalloidin, which directly 
modify cytoskeletal proteins, cause similar cell sur- 
face alterations in isolated hepatocytes [5,6]. 
The molecular basis of plasma membrane bleb- 
bing is presently unknown. However, during re- 
cent years the mechanisms by which individual 
cytoskeletal proteins interact have been extensively 
investigated, and calcium ions have been shown to 
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play a critical role in the modulation of 
cytoskeletal structure and function. Through its 
ability to regulate the activity of cytoskeletal 
Ca*+-binding proteins, Ca*+ can control the 
assembly of the major constituent proteins of the 
cytoskeleton, actin and tubulin [7]. Alternatively, 
changes in cytoskeletal structure may be mediated 
by catabolic enzymes, some of which are activated 
by increased cytosolic Ca*+ concentration, e.g. 
Ca*+-dependent proteases [8]. Such proteases have 
now been isolated from a variety of cells, including 
hepatocytes [9], and shown to catalyze the 
degradation of cytoskeletal proteins in platelets 
[lo] and to be involved in the Ca*+-activated pro- 
teolysis in muscle associated with pathological pro- 
cesses such as hereditary dystrophies and 
hypertrophy [ 111. 
We have previously shown that several toxic 
agents exert their effects on isolated hepatocytes 
through alterations of intracellular thiol and Ca*+ 
homeostasis, and that an increase in cytosolic Ca*+ 
concentration is associated with the appearance of 
plasma membrane blebs [12]. More recently, we 
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have found that exposure of hepatocytes to the 
reactive disulfide, cystamine, causes an increase in 
cytosolic Ca’+ concentration which is associated 
with a stimulation of intracellular proteolysis and 
loss of cell viability [ 131. The finding that pretreat- 
ment of the hepatocytes with inhibitors of 
Ca’+-activated, cytosolic proteases could prevent 
both the stimulation of proteolysis and the loss of 
cell viability suggested that Ca’+-activated pro- 
teases may be responsible for the toxicity of 
cystamine in hepatocytes [131. 
We now report that plasma membrane blebbing 
caused by three different agents (cystamine, ATP, 
and ionophore A23187) in isolated hepatocytes is 
associated with enhanced rates of protein degrada- 
tion, and that both surface blebbing and stimula- 
tion of proteolysis can be prevented by inhibitors 
of Ca2+ -activated proteases. 
hepatocytes were washed in Krebs-Henseleit buffer 
and subsequently incubated in the same buffer at 
37°C at a concentration of 1 x lo6 cells/ml in the 
presence or absence of the substrate tested. In the 
experiments with the inhibitors, these agents were 
added at the time indicated in the text and figure 
legends. Samples (0.4 ml) were taken at different 
times and processed as reported in [16]. The rate of 
intracellular proteolysis is expressed as percentage 
of HC104-soluble 14C radioactivity, at any given 
time point, vs total radioactivity at the beginning 
of the incubation. 
Scanning electron microscopy of hepatocytes 
was performed according to standard procedures 
involving glutaraldehyde and osmium fixation, 
followed by critical point drying and visualization 
in a Jeol scanning electron microscope (model 
HSM 35). 
2. MATERIALS AND METHODS 3. RESULTS AND DISCUSSION 
Collagenase (grade II) and leupeptin were ob- 
tained from Boehringer, Mannheim. Quin 
2-tetraacetoxymethyl ester and [14C]valine (spec. 
act. 280 mCi/mmol) were purchased from Amer- 
sham. Cystamine, ATP, antipain, 3-methyl- 
adenine, methylamine were from Sigma (St. Louis, 
MO). All other reagents were of the highest grade 
of purity available and were obtained from local 
commercial sources. 
Hepatocytes were isolated from male 
Sprague-Dawley rats (180-200 g, allowed food 
and water ad libitum) by collagenase perfusion of 
the liver as described [14]. Hepatocytes were in- 
cubated at a concentration of 1 x lo6 cells/ml in a 
Krebs-Henseleit buffer, supplemented with 12.5 
mM Hepes, pH 7.4, and equilibrated with 95% 
02:5% CO?, at 37°C. Cell viability was assessed 
by counting the percentage of cells excluding 
trypan blue. Cytosolic Ca2+ concentration was 
assessed by the fluorometric measurement of the 
Ca2+-quin 2 complex according to Cooper et al. 
[ 151, as described in detail in 1131, using a Sigma 
ZW II spectrophotometer equipped for 
fluorescence measurements. The rate of in- 
tracellular proteolysis was assessed according to 
Seglen et al. [16]. The labelling of proteins in vivo 
was achieved by intraperitoneal injection of 0.5 ml 
[i4C]valine (50&i), dissolved in 0.9% NaCl, 16 h 
prior to hepatocyte isolation. The freshly isolated 
The agents employed in this study have all been 
found to alter the balance between influx and ef- 
flux of Ca2+ in hepatocytes. Thus, the incubation 
of hepatocytes with cystamine or extracellular 
ATP inhibits Ca2+ efflux, resulting in intracellular 
Ca2+ accumulation and elevation of cytosolic Ca2+ 
concentration. The mechanism by which cystamine 
inhibits Ca2+ efflux is related to its ability to form 
mixed disulfides with plasma membrane protein 
thiols, thereby affecting thiol-dependent plasma 
membrane Ca2+ translocase activity [ 131. The ex- 
posure of hepatocytes to extracellular ATP is also 
associated with the inhibition of Ca2+ efflux [17], 
although the mechanism of the ATP effect is less 
clear [18]. The third agent employed in this study, 
ionophore A23 187, mediates a concentration- 
dependent movement of Ca2+ across cellular mem- 
branes. In the presence of physiological levels of 
Ca2+ in the incubation medium, A23187 therefore 
induces rapid entry of Ca2+ into the cells and a 
marked increase in cytosolic Ca2+ concentration. 
As shown in fig.1, all three agents (cystamine, 
ATP and A23187) caused plasma membrane bleb- 
bing in hepatocytes, the appearance of which was 
associated with an increased rate of proteolysis 
(fig.2). The addition of inhibitors of 
Ca2+-activated proteases to the medium prior to 
incubation of hepatocytes with the three agents 
prevented the onset of cell blebbing (fig.1) and 
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Fig. 1. Onset of plasma membrane blebbing in hepatocytes treated with agents that increase cytosolic Ca*+ concentra- 
tion, and protective effects of protease inhibitors. Hepatocytes were preincubated for 30 min in the absence or presence 
of protease inhibitors (leupeptin, lOOpg/ml; antipain, SO PM). At 30 min the different agents were added and, when 
indicated, the percentage of cells exhibiting surface blebs was counted using a light microscope. Symbols. Panel A: con- 
trol (0); 1 mM cystamine (A); 1 mM cystamine + leupeptin (A); 1 mM cystamine + antipain (0). Panel B: control 
(0); 1 mM ATP (m); 1 mM ATP + antipain (0); 1 mM ATP + leupeptin (A). Pancel C: control (0); 15 /rM A23187 
(II); 15 ,uM A23187 k antipain (0); 15 ,uM A23187 + leupeptin (A). 
I 
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Fig.2. Stimulation of intracellular proteolysis by agents that increase cytosolic Ca*+ concetration and effects of protease 
inhibitors. Hepatocytes, isolated 16 h following i.p. injection of 50&i [‘4C]valine, were preincubated at 37°C (1 x lo6 
cells/ml) for 30 min in the absence or presence of protease inhibitors. After 30 min, the various agents were added and 
the incubation continued. When indicated, 0.4 ml samples were removed from the incubation, and the rate of in- 
tracellular proteolysis was assessed as outlined in section 2. Symbols. Panel A: control (0); 1 mM cystamine (0); 1 mM 
cystamine + lOO,ug/ml leupeptin ( q ); 1 mM cystamine + 50pM antipain (A). Panel B: control (0); 1 mM ATP (w); 
1 mM ATP + 100 yg/ml leupeptin (A); 1 mM ATP + 50pM antipain (A). Panel C: control (0); 15 pM A23187 (m); 
15 /rM A23187 + 50pM antipain (A); 15 +M A23187 + lOOpg/ml leupeptin (A). 
markedly decreased the rate of proteolysis (fig.2). 
The effect of one of these inhibitors, leupeptin, on 
ATP-mediated hepatocyte blebbing is shown in 
fig.3. 
To determine if several proteolytic systems were 
involved in the observed stimulation of protein 
degradation in hepatocytes exposed to cystamine, 
ATP, or A23187 different classes of inhibitors 
were tested. Lysosomotropic agents, such as 
methylamine and chloroquine, as well as the in- 
hibitor of autophagy, 3-methyladenine, and serine 
protease inhibitors, i.e. trypsin inhibitor, were all 
unable to prevent the onset of plasma membrane 
blebbing. In contrast, leupeptin and antipain, 
which also inhibit non-lysosomal Ca2+-dependent 
proteases, prevented both the stimulation of pro- 
teolysis and the formation of plasma membrane 
blebs caused by exposure of hepatocytes to 
cystamine, ATP, or ionophore A231287. 
Moreover, the latter inhibitors also prevented the 
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Fig.3. Scanning electron micrographs of hepatocytes in- 
cubated in the absence (A) or presence (B,C) of 1 mM 
ATP: in (C) the hepatocytes were preincubated with 100 
@g/ml leupeptin for 30 min prior to addition of 1 mM 
ATP. Samples were taken 6 min after the addition of 
ATP. Magnifications: (A,C) x 4000 and (B) x 2500. 
loss of viability of hepatocytes exposed to 
cystamine or ATP and markedly diminished the 
cytotoxic effect of A23 186 (table 1). 
Similar to their lack of effect on surface bleb- 
bing, methylamine and 3-methyladenine were 
unable to prevent the cytotoxicity induced by the 
three agents, further supporting the assumption 
that lysosomal proteases were not involved in the 
proteolysis caused by the rise in cytosolic Ca’+. 
Moreover, leupeptin and antipain did not exert 
their protective effects through modification of 
cytosolic Ca’+, inasmuch as they did not prevent 
the rise in cytosolic Ca2+ caused by the three 
agents. Fig.4 shows an experiment in which pre- 
treatment of hepatocytes with leupeptin had no ap- 
parent effect on the increase in cytosolic Ca2+ in 
hepatocytes exposed to extracellular ATP, al- 
though this treatment protected the hepatocytes 
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Table 1 
Cytotoxicity in hepatocytes treated with agents that increase cytosolic Ca’+ concnetra- 
tion, and effects of various protease inhibitors 
Agents Incubation Trypan blue permeability, percentage of cells 
time 
Control Leupeptin Antipain Methylamine 3-Methyl- 
adenine 
Control 30 min 9*3 lO*l 7f3 12*1 11+2 
ATP, 1 mM 30 min 50_+6 12+6 12_+4 52_+2 52k7 
A23187, 
15 pM 30 min 65k2 25k2 28+2 66+5 6Ok3 
Control 180 min 19k6 16k5 12*2 22&l 24k3 
Cystamine, 
1 mM 180 min 58k7 16k5 18*4 55-t4 62+_8 
Hepatocytes were preincubated for 20 min in the absence or presence of protease in- 
hibitors (leupeptin, 100 /cg/ml; antipain, 50 /rM; methylamine, 10 mM; 
3-methyladenine, 5 mM). At 20 min the various agents were added and, when in- 
dicated, the percentage of cells permeable to trypan blue was counted in a light 
microscope. Values are expressed as means f SD of 5 different experiments. 
from both surface blebbing and loss of viability. 
It is not yet known which proteins are substrates 
for Ca2+-activated proteolysis. However, our 
observation that inhibitors of Ca’+-activated pro- 
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Fig.4. Increase in cytosolic Ca2+ level in control and 
leupeptin-treated hepatocytes after addition of 1 mM 
ATP. Quin t-loaded hepatocytes were incubated in a 
cuvette maintained at 37”C, where the hepatocytes were 
continuously stirred under an atmosphere of 95% 
02: 5% CO2. Cytosolic Ca2+ measurements were per- 
formed as indicated in section 2. Leupeptin-treated 
hepatocytes were preincubated in the presence of the 
protease inhibitor for 10 min prior to loading with quin 
2 AM. Symbols: control (0); 1 mM ATP (w); lOOpg/ml 
leupeptin + 1 mM ATP (A). 
teases prevent the onset of blebbing, suggests that 
cytoskeletal proteins may be targets for the pro- 
teolytic activity. Furthermore, our results support 
the assumption that plasma membrane blebbing is 
an early sign of toxicity in hepatocytes and suggest 
that Ca2+ -activated proteases may play an impor- 
tant role in the development of cytotoxicity 
resulting from disruption of intracellular Ca2+ 
homeostasis. They also provide a possible link be- 
tween the inhibition of plasma membrane Ca2+ 
translocase activity, suggested to be a critical 
biochemical esion of several hepatotoxins [13,191, 
and cytotoxicity. Although we do not exclude that 
other mechanisms may be equally important in 
causing toxic damage to hepatocytes, experimental 
evidence for their nature and role in hepatocyte 
blebbing and toxicity is presently lacking. 
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